R

Rallybio

51 employees

Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Biopharma
Rare Disease

Date founded

2018

Funding rounds raised

Total raised

$145M

from 9 investors over 9 rounds

R

Rallybio raised $145M on April 14, 2020

Investors: Tekla Capital Management, Fairview Capital Partners, New Leaf Venture Partners, Solasta Ventures, Viking Global Investors and F-Prime Capital Partners

R

Rallybio raised $37M on April 25, 2018

Investors: Canaan, New Leaf Venture Partners and 5AM Ventures

FAQ